MAPT and epilepsy: CSF levels of VILIP‐1 and VILIP‐1/Aβ42 showed comparable predictive abilities for total cognitive decline as tau and tau/Aβ42.91,92 Serum VILIP‐1 is considered a better biomarker for epilepsy and seizure‐induced neuronal injury.